by Truveta Research | Oct 31, 2022 | Research, Research Insights
On February 17, 2022, Abbott voluntarily recalled powdered formula made in a Michigan facility due to complaints of Cronobacter sakazakii and Salmonella Newport contamination [1]. Datasembly reported that baby formula was out-of-stock at 31% of stores in April 2022...
by Truveta Research | Oct 4, 2022 | Research, Research Insights
Peripheral Artery Disease (PAD) is a common disease that causes the arteries in the extremities to narrow. Recently, as part of PAD Awareness Month, we investigated disparities in the frequency of common procedures used to treat PAD, known as endovascular (or...
by Truveta Research | Sep 27, 2022 | Research, Research Insights
Peripheral artery disease (PAD) is a common disease that causes narrowing of the arteries in the extremities. The lifetime risk for Americans varies between 19-30% [1]. Many studies have shown that PAD disproportionately affects both Black or African American...
by Truveta Research | Sep 22, 2022 | Research, Research Insights
Early in the pandemic, very little was known about the best treatment pathways for COVID-19, and there were no approved drug therapies available. Doctors were quoted saying, “To be honest, we didn’t know [how to treat patients]” [1]. The first approved COVID...
by Truveta Research | Sep 15, 2022 | Research, Research Insights
COVID-19 impacted communities disproportionately [1]. Especially in the early days of the pandemic, countless reports of inequitable access to treatments and treatment pathways brought to light existing and new disparities in health outcomes [2]. Addressing health...
by Truveta Research | Sep 12, 2022 | Research, Research Insights
At the start of the pandemic, clinicians around the world were struggling for answers. No one knew the best ways to treat patients with COVID-19 infections – when to intubate, which treatments actually work, and more. That’s why more than 20 U.S. health systems have...
